Cheshire East Community Health. Controlled Drug / Syringe Driver Prescription and Administration Record

Similar documents
END OF LIFE MEDICINES INFORMATION PACK

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Community Pharmacists in NHS Rotherham

Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013

MEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts

Guidelines for the Use of Subcutaneous Medications in Palliative Care

Examples of Good Practice Resource Guide

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

On Demand Availability of Palliative Care Drugs Service

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

Guide to the Pharmacological Management of End of Life (Terminal) Symptoms in Residential Aged Care Residents

How To Take A Strong Opioid Painkiller

Clinical protocol for the use of syringe drivers in palliative care patients (adults)

A Guide to pain relief medicines For patients receiving Palliative Care

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

Pharmaceutical care of people requiring palliative care Course activities

OPIOIDS CONVERSION GUIDELINES 2007

Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme

Opioid Conversion Ratios - Guide to Practice 2013

Collaborative Care Plan for PAIN

Nurses Self Paced Learning Module on Pain Management

Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal

Opioids in Palliative Care- Patient Information Manual

Local Enhanced Service Contract Supply Nene CCG of Drugs for use in Palliative Care by Community Pharmacies in Nene CCG and Corby CCG

Strong opioids (painkillers) in palliative care what you should know

Implementing stock end-of-life medication in UK nursing homes. Kathy Morris, Jo Hockley

GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Version: 2

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Pain management. The WHO analgesic ladder

All Wales Prescription Writing Standards

Guidelines for the use of Methadone for Adults with Pain in Palliative Care

Opioid Conversion Ratios - Guide to Practice 2010

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach

WITHDRAWAL OF ANALGESIA AND SEDATION

Parenteral Dosage of Drugs

Opioid toxicity and alternative opioids. Palliative care fixed resource session

D( desired ) Q( quantity) X ( amount ) H( have)

Abstral Prescriber and Pharmacist Guide

Humulin R (U500) insulin: Prescribing Guidance

Electronic Medical Record (EMR) Safety Results of CAH Testing. Tom Johns, PharmD Shands at the University of Florida

Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults

SWL Supportive and Palliative Care Group and SWL Cardiac Network. Symptom Control Guidelines and key information in end-stage heart failure

Standard Operating Procedure

! # # # %# # & # ( ) +,. / % # )., 0,, 5((/ + 6 0,67 8,+,, + 6,67, 7 6

DRUG DOSE CALCULATIONS

Guidelines for the Use of Naloxone in Palliative Care in Adult Patients

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

Subcutaneous Medications and Palliative Care: A guide for caregivers

Welcome to the Internal Medicine Intern Teaching Course

Symptom Control and Caring for the Dying Patient: Palliative Care Guidelines 4th Edition

What is hospice care? Answering questions about hospice care

Narcotic drugs used for pain treatment Version 4.3

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

Crisis Management in Hospice Patients

Palliative Care Integrated Clinical Pathway

Anticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.

Your A-Z of coping with nausea and vomiting A guide for patients and their carers. We care, we discover, we teach

AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less)

Medication Administration Competency Assessment Toolkit

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

Review of Pharmacological Pain Management

LDU Maths, Stats and Numeracy Support. Metric Conversions

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol

Section 2 Solving dosage problems

Pain is a symptom people associate with a malignant illness and is common in non malignant disease.

MODERATE SEDATION RECORD (formerly termed Conscious Sedation)

DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline

Safe Medication Administration Preparation Guide C.O.R.E Essentials

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

Naloxone treatment of opioid overdose

End of Life Care in Advanced Kidney Disease

CORONER S REPORT REPORT

Nurse Initiated Medications Procedure

Southlake Psychiatry. Suboxone Contract

Welcome to the Internal Medicine Intern Teaching Conference Series

Good Practice Guidance: The safe management of controlled drugs in care homes

Patient information. Using strong Opioids to control your pain

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

First published in 2006 as Guidelines for syringe driver management in palliative care. Reprinted 2007

MUSC Opioid Analgesic Comparison Chart

Pain Management in Palliative and Hospice Care

If you have any questions, please do not hesitate to contact us. We look forward to meeting you!

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride

Reconstitution of Solutions

Palliative Care The Relief You Need When You re Experiencing the Symptoms of Serious Illness

UNIT VIII NARCOTIC ANALGESIA

Donepezil (Aricept ), Galantamine (Reminyl XL ), Rivastigmine (Exelon ) and Memantine (Ebixa )

Getting the best result from Opioid medicine. in the management of chronic pain

Post-operative Pain Management

Acute management of Parkinson s

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Caring for the Dying Patient (CDP) Document

When calculating how much of a drug is required, working with the formula helps the accuracy of the calculation.

Transdermal and Parenteral Fentanyl Dosage Calculations and Conversions

How to take your Opioid Pain Medication

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

Transcription:

Syringe Driver Use Consider its use if the patient is unable to swallow or has nausea/vomiting, also in the terminal stages. Use a ml or ml luer lock syringe. Use water for injection as the diluent. Commonly Used Syringe Driver s are: Diamorphine - for pain known or likely to be opioid sensitive - may accumulate in Renal failure. If previously on morphine, take total dose of oral morphine and divide by 3 to calculate total amount of diamorphine to be used in syringe driver over 24 hour period. If not previously on an opioid, start at -mg over 24 hours. Vials available as,, & 0mg pack sizes. + 00mg. Oxycodone - can be used as an alternative for diamorphine. To calculate SC dose of oxycodone from oral dose - use two thirds of the oral dose. If breakthrough dose > mg prescribe diamorphine as oxycodone injection may be painful. Vials mg/ml - 1ml & 2ml amps - pack size. Haloperidol - for nausea due to medication, renal/liver failure, or if cause unknown; also antipsychotic. range: for nausea 2. to mg over 24 hours; for delirium to mg over 24 hours. Vials mg/ml - 1 ml amp - pack size. Cyclizine - nausea due to intra-abdominal disease, cough or brain tumour. Avoid in severe heart failure. range 0 to 0mg over 24 hours (may be up to 0mg over 24 hours - seek advice). May crystallize (goes cloudy) in high doses in combination with other drugs. Vials 0mg/ml - 1 ml amp - pack size. Levomepromazine (Nozinan) - if above fail, and/or for terminal agitation/delirium. range 6.2 to 2mg over 24 hours (antiemetic); 2 to mg over 24 hours (terminal agitation). Make as dilute as possible (use a or ml syringe). Vials 2mg/ml - 1 ml amp - pack size. Midazolam (Hypnovel) - First Line sedative for terminal agitation; anticonvulsant properties, including myoclonus. dose range to mg over 24 hours; may be as high as 1mg over 24 hours (seek advice). Vials mg/ml - 2 ml amp - pack size. Glycopyrronium for moist, noisy breathing in the terminal stages. range 0 to micrograms over 24 hours. Vials 0 microgram/ml - 1 ml & 3 ml amps - pack size. Could use Hyoscine butylbromide as alternative - to 1mg over 24 hours. Vials mg/ml - 1 ml amp - pack size. Water for Injections - prescribe ml amps - pack size. This should be prescribed by GP. Booklet No. NHS No. Cheshire East Community Health Controlled / Syringe Driver Prescription and Administration Record Surname Forenames Mr. of Birth Mrs. Miss. Address Tel. No. Macmillan Nurse Own G.P. Practice Name Tel. No. of Practice Named District Nurse Sensitivites Contact Number Macmillan Nurse 24 Hour Hospice Advice Line 24 Hour Hospice Advice Line St. Lukes: 016 1246 East Cheshire Hospice: 0162 666999 List of Patient s Controlled s Not administered by District / CECH Staff Name of Dosage Frequency Route Usually administered by Transdermal drug Fentanyl (Durogesic) patch - for pain control. Not started in terminal phase. 2 microgram/hour patch is roughly equivalent to to 90mg oral morphine per day. Patch changed every 72 hours (3 days). Occasionally, this needs to be reduced to every 48 hours. Breakthrough analgesia is mg diamorphine subcutaneously for every 2mcg/hr of fentanyl. If pain worsening during terminal phase, continue fentanyl and add diamorphine in syringe driver. As Needed drugs. All can be given subcutaneously The six drugs should be available in the patient s home and prescribed in the doses stated except the diamorphine range which will need to be calculated Diamorphine - use one sixth of total 24 hour diamorphine dose, usually 2 to 4 hourly. Levomepromazine - 6.2 to 12.mg (nausea), 12. to 2mg (delirium), 3 hourly. Midazolam (Hypnovel) - stat dose for restlessness (which may be caused by pain, positional discomfort, urinary retention or constipation) is 2. to mg, 3 hourly. For sedation during haemorrhage, Midazolam mg may need to be repeated at minute intervals. there is a special buccal preparation which can be given by carers. Glycopyrronium - 0 to 0 micrograms, 3 hourly. If not avaiable, use Hyoscine Butylbromide AS mg stat dose repeated 3 hourly. Haloperidol - 1.mg to mg - For nausea. Cyclizine up to 4x a day for nausea. Advice from specialist palliative care service (Monday-Friday 9-) telephone (East) 0162 663177. (Central) 016 1246. For more information see palliative care section at the front of the British National formulary (BNF). Information about drug combinations can be found at the back of the PCT syringe driver guidelines. For out of hours advice please contact either East Cheshire Hospice Staff 0162 666999 or St Lukes Hospice 016 1246. Code:- pct/dn8 Review date February Syringe Driver Serial No. Serviced record Weekly Battery Changes Driver 1 / Driver 2 / Doctor Prescriber 1 Use approved Names, Block Letters, Metric Dosage (opioids by mg/mcg) & English instructions. Avoid abbreviations. 2 Prescribe Changes in drug therapy on a New Prescription line. Do not alter existing instructions. 3 discontinue a drug by drawing a line through the prescription. Enter the date of cancellation and your initials. 4 All Prescriptions should be reviewed regularly. Nurse 1 Check the entries in each section before administration of the drug(s). 2 The nurse giving the drug Must complete the Administration Record and sign, after the drugs have been administered. 3 Ensure all drugs are signed and prescribed by a doctor.

Syringe Driver Transdermal / Oral Medication Where dose range given start at lowest dose Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Conversion Chart Table 33 Converting from Oral Morphine to Fentanyl Transdermal Patches 24-hrly morphine dose Fentanyl Transdermal Oral short-acting morphine (mg) (microgram/h) breakthrough dose 1 3 4 7 90 1 13 16 1 2 37 0 62 7 0 12 17 0 22 27 0-90 90-134 13-189 190-224 22-314 31-4 - 494 49-84 8-674 67-764 76-84 8-944 94-34 3-1124 In the case of end of life, patients who are established on transdermal patch and have increasing pain control issues refer to ICP (integrated care pathway) information on symptom control guidelines. Doctors Line Change Y/N Driver 1 Driver 2 Syringe Driver Rate Site - Syringe Driver 1 Site - Syringe Driver 2

Greater Manchester and Cheshire Cancer network conversion chart Table 31 Opioid Conversion Charts (note: - rounded to convenient doses) Morphine Diamorphine Oxycodone Hydromorphone mg mg mg mg Oral SC SC Oral SC Oral Route total 4 hrly CSCI 4 hrly total 4 hrly CSCI 4 hrly CSCI 4 hrly total 1.3 1.3 2.6 2.6 3.9 3.9 4.2 7.8.4 13 16.9.8 26 4 8 12 16 24 32 48 64 4 128 1 2. 7. 1 2 70 0 1 1 0 2 3 0 2. 7. 12. 1 0 6 0 1 4 7 90 1 1 2 0 0 00 0 2. 7. 1 2 70 0 1 1 0 2 3 0 2. 7. 12. 1 0 6 0 1 4 7 90 1 1 2 0 0 00 0 1 2 0 1 1 0 90 1 1 2 3 4 0 0 00 This table does not indicate incremental steps. Increases are normally in -0% steps - more, if indicated by need for p.r.n. doses. SC volumes > 2ml are uncomfortable: oxycodone maximum concentration is mg/ml, and morphine is mg/ml: consider using 2 injection sites per p.r.n. dose or unless contra-indicated use equivalent diamorphine. Conversion factors: From oral morphine to SC morphine - divide by 2 From oral morphine to SC diamorphine - divide by 3 From oral morphine to oral oxycodone - divide by 1. to 2 (calculated as 1. above) From oral morphine to oral hydromorphone - divide by 7. From oral oxycodone to SC oxycodone - divide by 2 From oral morphine (total per 24h) to fentanyl skin patch (mcg/h) - give 2mcg/h of Fentanyl for every 90mg of morphine From SC diamorphine (total per 24h) to fentanyl skin patch (mcg/h) - give 2mcg/h of Fentanyl for every mg of diamorphine Other opioids: Oral tramadol to oral morphine (total per 24h) - divide by

Stock Record Controlled and Strength New Stock Total Stock Exp. Controlled and Strength New Stock Total Stock Exp.

Stock Record Controlled and Strength Controlled and Strength New Stock Total Stock Exp. New Stock Total Stock Exp.

Injections to be given on a PRN basis (These drugs should be available in patient s home) PRN or Statutory dose 2 hourly (longer in renal failure) range Route Frequency SC Usually 2 to 4 Hourly Doctors Usual Max Dosage(1mg/) Route Frequency 1. to mg SC 3 Hourly Doctors Doctors Usual Max Dosage(7mg/) Route Frequency 6.2 to 2mg SC 3 Hourly Doctors Usual Max Dosage(1mg/) dose range 2. to mg (mg for catastrophic event only) range Route Frequency SC 3 Hourly Doctors Usual Max Dosage(mcg/) Route Frequency 0 to 0 Mircro gram SC 3 Hourly Doctors Route Frequency SC Doctors Diamorphine Haloperidol Maximum (0mg/) to include Syringe Driver content cyclizine Levomepromazine Midazolam Glycopyrronium Water for injections Route Frequency 0mg SC 4/6 Hrly - 0 MG/Day Stock Record Controlled and Strength Controlled and Strength New Stock Total Stock Exp. New Stock Total Stock Exp.

Stock Record Controlled and Strength Controlled and Strength New Stock Total Stock Exp. New Stock Total Stock Exp.

Stock Record Controlled and Strength New Stock Total Stock Exp. Controlled and Strength New Stock Total Stock Exp.

Stock Record Controlled and Strength Controlled and Strength New Stock Total Stock Exp. New Stock Total Stock Exp.

Additional s Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors Route Frequency Doctors